Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of TB006 in Participants With Alzheimer's Disease
Clinical trial NCT05074498 · COMPLETED
Trial details
- NCT number
- NCT05074498
- Sponsor
- TrueBinding, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-08
- Primary completion
- 2022-10-13
- Enrollment
- 154
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.